142 related articles for article (PubMed ID: 16754599)
1. Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.
Jones E; Alvarez Secord A; Prosnitz LR; Samulski TV; Oleson JR; Berchuck A; Clarke-Pearson D; Soper J; Dewhirst MW; Vujaskovic Z
Int J Hyperthermia; 2006 Mar; 22(2):161-72. PubMed ID: 16754599
[TBL] [Abstract][Full Text] [Related]
2. Palliative benefit of external-beam radiation in the management of platinum refractory epithelial ovarian carcinoma.
Gelblum D; Mychalczak B; Almadrones L; Spriggs D; Barakat R
Gynecol Oncol; 1998 Apr; 69(1):36-41. PubMed ID: 9570996
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal cis-platinum as salvage therapy for refractory epithelial ovarian cancer.
Hacker NF; Berek JS; Pretorius RG; Zuckerman J; Eisenkop S; Lagasse LD
Obstet Gynecol; 1987 Nov; 70(5):759-64. PubMed ID: 3658287
[TBL] [Abstract][Full Text] [Related]
4. Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy.
Tarraza HM; Boyce CR; Smith WG; Jones MA
Gynecol Oncol; 1993 Sep; 50(3):287-90. PubMed ID: 8406188
[TBL] [Abstract][Full Text] [Related]
5. Whole-abdomen radiation therapy as salvage treatment for epithelial ovarian carcinoma.
Sedlacek TV; Spyropoulus P; Cifaldi R; Glassburn J; Fisher S
Cancer J Sci Am; 1997; 3(6):358-63. PubMed ID: 9403049
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cisplatin and cyclosporin A in recurrent platinum-resistant ovarian cancer: a phase II study of the gynecologic oncology group.
Manetta A; Blessing JA; Hurteau JA
Gynecol Oncol; 1998 Jan; 68(1):45-6. PubMed ID: 9454659
[TBL] [Abstract][Full Text] [Related]
7. Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer.
Rietbroek RC; Bakker PJ; Schilthuis MS; Postma AJ; Zum Vörde Sive Vording PJ; Gonzalèz Gonzalèz D; Kurth KH; Bakker AJ; Veenhof CH
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):887-93. PubMed ID: 8598366
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines.
van de Vaart PJ; van der Vange N; Zoetmulder FA; van Goethem AR; van Tellingen O; ten Bokkel Huinink WW; Beijnen JH; Bartelink H; Begg AC
Eur J Cancer; 1998 Jan; 34(1):148-54. PubMed ID: 9624250
[TBL] [Abstract][Full Text] [Related]
9. [Thermoradiotherapy combined with daily administration of low dose cisplatin for locally advanced laryngeal carcinoma].
Hinohira Y; Yumoto E; Hyodo M; Kawamura M; Kataoka M; Fujii T; Ueda N
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1961-5. PubMed ID: 9350243
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells.
Raaphorst GP; Miao J; Ng CE
Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189
[TBL] [Abstract][Full Text] [Related]
11. A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment.
Raaphorst GP; Doja S; Davis L; Stewart D; Ng CE
Cancer Chemother Pharmacol; 1996; 37(6):574-80. PubMed ID: 8612312
[TBL] [Abstract][Full Text] [Related]
12. Combined chemotherapy and hyperthermia for ovarian cancer studied at Duke.
Oncology (Williston Park); 1990 May; 4(5):134. PubMed ID: 2143398
[No Abstract] [Full Text] [Related]
13. [Augmentative effects of radiofrequency hyperthermia (RFH) combined with intraperitoneal (IP) administration of CDDP in ovarian cancer].
Ino Y; Takizawa K; Isono T; Sato M; Yokoo I; Iguchi T; Takeda Y; Yokoyama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1887-91. PubMed ID: 3382241
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic analysis of intra-peritoneal administration of cisplatin].
Terashima M; Ikeda K; Takagane A; Sasaki N; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Nakaya T; Oyama K; Saito K
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1859-62. PubMed ID: 9382551
[TBL] [Abstract][Full Text] [Related]
15. Regional hyperthermia with BSD-1000 annular phased array in the management of recurrent deep seated malignant tumors.
Petrovich Z; Emami B; Astrahan M; Langholz B; Luxton G
Strahlenther Onkol; 1987 Jul; 163(7):430-3. PubMed ID: 3616899
[No Abstract] [Full Text] [Related]
16. [Clinical application of local hyperthermia combined with antineoplastic agents].
Ishiwata J; Sasaki T; Iwamoto S; Koike M; Maeda Y; Takeshita Y; Tanaka Y; Masuda T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2114-21. PubMed ID: 3933434
[TBL] [Abstract][Full Text] [Related]
17. [Significance of the sequence of therapeutic procedures in the combined treatment of ovarian cancer patients (based on the criterion of the onset and duration or remission)].
Zadontseva NS
Vopr Onkol; 1985; 31(12):57-61. PubMed ID: 4082509
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma.
Leopold KA; Oleson JR; Clarke-Pearson D; Soper J; Berchuck A; Samulski TV; Page RL; Blivin J; Tomberlin JK; Dewhirst MW
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1245-51. PubMed ID: 8262854
[TBL] [Abstract][Full Text] [Related]
19. [Local injection of cisplatin for vaginal stump recurrence of gynecological malignant tumor].
Sato Y; Igarashi S; Kushima T; Tanaka T
Gan To Kagaku Ryoho; 1998 Feb; 25(3):409-12. PubMed ID: 9492836
[TBL] [Abstract][Full Text] [Related]
20. Thermochemotherapy for cancer of the tongue using magnetic induction hyperthermia (implant heating system: IHS).
Tohnai I; Hayashi Y; Mitsudo K; Kobayashi T; Matsui M; Ueda M
Nagoya J Med Sci; 1996 Mar; 59(1-2):49-54. PubMed ID: 8725488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
